National Center for Research Resources (NCRR): Virus Diseases trials
The registry lists 10 Virus Diseases studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 3Phase 3 6No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and MouthCompletedNCT00006135Phase 3
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous SystemStatus unknownNCT00006132Phase 3
- Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
- Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and MouthCompletedNCT00004757Phase 3
- Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-WastingCompletedNCT00004664Not applicable
- Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus InfectionCompletedNCT00004644Phase 1/2
- Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System DiseaseCompletedNCT00004642Phase 1/2
- Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic NeuralgiaCompletedNCT00004390Phase 3
- Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus InfectionCompletedNCT00004278Phase 3
- Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV InfectionsCompletedNCT00004276Phase 2